Semaglutide: The Groundbreaking Weight-loss Drug That Reduces Cardiovascular Disease Risk

2023-11-16 06:31:19

Al-Marsad newspaper: An international team of scientists discovered that the famous weight-loss drug semaglutide can reduce the risk of cardiovascular disease.

According to the New England Journal of Medicine, the aforementioned drug can reduce the risk of cardiovascular diseases, including myocardial infarction and stroke, in obese people by 20 percent.

It is noteworthy that semaglutide was originally prescribed for people with type 2 diabetes, but its use has recently increased in weight loss in adults who suffer from overweight and at least one other health problem.

1700129776
#Discovery #common #weightloss #drug #reduces #incidence #heart #disease #AlMarsad #newspaper

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

Zhou Tiancheng’s Victory in Super 500 Series Japan Badminton Masters

Chicago Bears QB Justin Fields Set to Return Against Detroit Lions – Big News for Bears Future

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.